Court Ruling Threatens Abortion Care, Says National Abortion Federation
The National Abortion Federation has criticized the Fifth Circuit’s decision in Louisiana v. FDA, stating that it will create medically unnecessary barriers to abortion care and disregards the well-established safety and efficacy of mifepristone via telehealth.